Sermorelin vs Ipamorelin: Research Guide 2026 (GHRH Analog vs Ghrelin Receptor Agonist)

RESEARCH

Published September 8, 2026

Sermorelin vs Ipamorelin: Research Guide 2026 (GHRH Analog vs Ghrelin Receptor Agonist)

Compliance notice: Sermorelin and ipamorelin are supplied strictly For Research Use Only — not for human consumption, not for veterinary use, not intended to diagnose, treat, cure, or prevent any disease. Nothing below is medical advice, and no dosing guidance is given or implied.

Sermorelin vs ipamorelin is one of the most common comparison searches in the growth-hormone secretagogue category, and it is usually framed the wrong way. These two research peptides are not two versions of the same thing. They are structurally unrelated molecules that act on two different receptors, and that single fact drives every practical difference between them — chemistry, purity expectations, and how each one is handled in the lab.

Table of Contents

The Short Answer

Sermorelin: GHRH Analog Chemistry

Ipamorelin: Pentapeptide Chemistry

The Mechanistic Difference That Matters

Purity: Why a 29-mer and a 5-mer Are Judged Differently

Reconstitution, Storage & Handling

Research FAQ

Sermorelin vs Ipamorelin: The Short Answer

Sermorelin is a 29‑amino‑acid analog of endogenous growth hormone‑releasing hormone (GHRH). It is studied at the GHRH receptor. Ipamorelin is a five‑amino‑acid synthetic pentapeptide studied at the ghrelin receptor, GHS‑R1a. Both are described in the literature as growth hormone secretagogues, but they reach that classification through separate receptor pathways.

Because the pathways are separate, the two are more often studied together as complementary probes than head‑to‑head as substitutes. That is also why the GHRH‑analog‑plus‑secretagogue pairing is such a common research combination — see our CJC‑1295 / ipamorelin research guide for how that pairing is characterized.

Sermorelin: GHRH Analog Chemistry and Identifiers

Sermorelin corresponds to the first 29 residues of human GHRH, the fragment generally described as GRF(1‑29) amide — the shortest sequence retaining the full biological activity of the parent hormone in published work. Commonly listed identifiers are:

CAS number: 86168‑78‑7

Molecular formula: C149H246N44O42S

Molecular weight: approximately 3,357.9 g/mol

Class: GHRH receptor agonist (peptide hormone analog)

Sermorelin is frequently supplied as the acetate salt, which carries its own CAS entry. Always confirm which form a lot represents against the certificate of analysis rather than assuming, because salt form affects the peptide content figure.

Sermorelin was previously available as a prescription product in the United States and was subsequently discontinued from that market. Research‑grade material sold today is not that product, is not released to pharmaceutical GMP specifications, and carries no prescribing label. For a closely related GHRH‑analog comparison, see our tesamorelin research guide.

Ipamorelin: Pentapeptide Chemistry and Identifiers

Ipamorelin is a short synthetic pentapeptide with the sequence Aib‑His‑D‑2‑Nal‑D‑Phe‑Lys‑NH2. Commonly listed identifiers are:

CAS number: 170851‑70‑4

Molecular formula: C38H49N9O5

Molecular weight: approximately 711.9 g/mol

Class: Ghrelin receptor (GHS‑R1a) agonist

Ipamorelin was introduced in the literature in a 1998 characterization paper in the European Journal of Endocrinology, which described it as a selective growth hormone secretagogue in the models studied. It has never held an approved human indication in any jurisdiction, and its clinical development programme was discontinued. It is a research compound and nothing else.

The Mechanistic Difference That Actually Matters

Sermorelin binds the GHRH receptor, a class B G‑protein‑coupled receptor expressed on pituitary somatotrophs. Ipamorelin binds GHS‑R1a, the receptor for the endogenous peptide ghrelin. Two different receptor families, two different upstream signals.

For study design, the consequence is that these compounds are not interchangeable controls for one another. Substituting one for the other changes which receptor is being interrogated, which makes any resulting comparison uninterpretable. If a protocol calls for GHRH‑receptor engagement, a ghrelin‑receptor agonist does not substitute for it, and the reverse is equally true.

Purity and COA: Why a 29-mer and a 5-mer Are Not Judged the Same Way

This is the practical point most sermorelin vs ipamorelin comparisons miss entirely. Synthesis difficulty scales with chain length. A 29‑residue peptide like sermorelin accumulates far more opportunities for deletion sequences, truncations, and incomplete couplings than a 5‑residue peptide like ipamorelin, and those related impurities elute close to the main peak.

What that means when you read the paperwork: on a long‑chain peptide, look hard at the HPLC trace itself, not just the headline purity percentage. Shoulders and closely eluting peaks matter. On a short peptide, a clean single peak is a more ordinary expectation, so an unclean one is a louder warning. In both cases the mass‑spec result should match the theoretical molecular weight above, and the lot number on the COA must match the lot number on the vial.

Our full walkthrough of that process is here: how to read a peptide COA.

Reconstitution, Storage and Handling Differences

Both compounds ship as lyophilized powder and are reconstituted with bacteriostatic water in the laboratory. Keep lyophilized material cold and protected from light; keep reconstituted material refrigerated, shielded from light, and away from repeated freeze‑thaw cycling. Add diluent down the vial wall and swirl — do not shake either peptide.

The difference worth noting is the concentration arithmetic. Vial strengths differ across the catalog, so the milligram figure on the label, not the compound name, determines the final concentration. Work it out per lot. Our step‑by‑step method is in how to reconstitute peptides, and the diluent question is covered in bacteriostatic water vs sterile water. General cold‑chain practice is in our peptide storage and handling guide.

Research FAQ

Is sermorelin the same as ipamorelin?

No. Sermorelin is a 29‑amino‑acid GHRH analog acting at the GHRH receptor. Ipamorelin is a 5‑amino‑acid pentapeptide acting at the ghrelin receptor, GHS‑R1a. They are structurally unrelated and are not interchangeable in a protocol.

What are the molecular weights of sermorelin and ipamorelin?

Sermorelin is commonly listed at approximately 3,357.9 g/mol and ipamorelin at approximately 711.9 g/mol. Confirm both against the mass‑spec figure on the lot‑specific certificate of analysis before use.

Which receptor does each one act on?

Sermorelin is characterized as a GHRH receptor agonist. Ipamorelin is characterized as a ghrelin receptor (GHS‑R1a) agonist. Both are described in the literature as growth hormone secretagogues, but by different pathways.

Are sermorelin and ipamorelin studied together?

A GHRH analog paired with a ghrelin‑receptor secretagogue is a widely described research combination precisely because the two pathways are distinct. That pairing is a design choice, not an equivalence.

How should each one be stored?

Lyophilized powder cold and protected from light. Once reconstituted, refrigerated, light‑protected, and not repeatedly frozen and thawed. Neither vial should be shaken.

Sourcing Sermorelin and Ipamorelin for Research

What separates a usable lot from an unusable one is documentation you can actually check: a lot‑matched COA, a real HPLC trace, a mass confirmation, and a recent test date.

Precision Labs supplies sermorelin 10mg and ipamorelin 10mg with lot‑matched third‑party analysis. If you want the current lot's documentation reviewed before ordering, or have a specification question for a particular protocol, contact our team — we will send the COA before you buy.

For Research Use Only. Not for human consumption. Not for veterinary use. Not intended to diagnose, treat, cure, or prevent any disease.